West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Location
530 Herman O. West Drive, Exton, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 283 % -0.54%
Quick Ratio 72.2 % +4.74%
Debt-to-equity 34.8 % +4.35%
Return On Assets 13.1 % -8.39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.9M shares -0.87%
Common Stock, Shares, Outstanding 71.9M shares -0.96%
Entity Public Float 23.9B USD -15.2%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 72.2M shares -1.1%
Weighted Average Number of Shares Outstanding, Diluted 72.5M shares -1.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 695M USD -2.96%
Revenue from Contract with Customer, Excluding Assessed Tax 2.96B USD +2.9%
Research and Development Expense 69.4M USD -0.72%
Operating Income (Loss) 582M USD -0.95%
Nonoperating Income (Expense) 17.6M USD +28.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 597M USD +22%
Income Tax Expense (Benefit) 124M USD +20.8%
Net Income (Loss) Attributable to Parent 488M USD -7.09%
Earnings Per Share, Basic 6 USD/shares -5.49%
Earnings Per Share, Diluted 6 USD/shares -4.98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 510M USD +14.2%
Accounts Receivable, after Allowance for Credit Loss, Current 582M USD +21.5%
Inventory, Net 421M USD +0.45%
Other Assets, Current 168M USD +21.3%
Assets, Current 1.68B USD +13.3%
Deferred Income Tax Assets, Net 29.7M USD -12.4%
Property, Plant and Equipment, Net 1.72B USD +15.3%
Operating Lease, Right-of-Use Asset 104M USD -5.35%
Intangible Assets, Net (Excluding Goodwill) 9.7M USD -24.8%
Goodwill 111M USD +3.36%
Other Assets, Noncurrent 70.5M USD +40.7%
Assets 3.95B USD +13.3%
Accounts Payable, Current 239M USD +12.9%
Liabilities, Current 605M USD -4.59%
Deferred Income Tax Liabilities, Net 23M USD +67.9%
Operating Lease, Liability, Noncurrent 79.8M USD -5.67%
Other Liabilities, Noncurrent 70.4M USD +11.6%
Liabilities 1.02B USD +12.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -88.7M USD +59.1%
Retained Earnings (Accumulated Deficit) 4.14B USD +11.2%
Stockholders' Equity Attributable to Parent 2.93B USD +13.7%
Liabilities and Equity 3.95B USD +13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 129M USD +9.48%
Net Cash Provided by (Used in) Financing Activities -147M USD +45.8%
Net Cash Provided by (Used in) Investing Activities -71.3M USD +21.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.4M USD +68.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 510M USD +14.2%
Deferred Tax Assets, Valuation Allowance 12.8M USD -17.4%
Operating Lease, Liability 101M USD -4%
Depreciation 39.1M USD +12.7%
Payments to Acquire Property, Plant, and Equipment 71.3M USD -21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 616M USD +25.3%
Lessee, Operating Lease, Liability, to be Paid 114M USD -5.34%
Property, Plant and Equipment, Gross 3.18B USD +11%
Operating Lease, Liability, Current 20.9M USD +2.96%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.2M USD -8.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 25.1M USD +10.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.8M USD -14.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.7M USD +9.15%
Deferred Tax Assets, Operating Loss Carryforwards 6.1M USD -39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 43.6M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.8M USD -7.25%
Operating Lease, Payments 6.1M USD +15.1%
Additional Paid in Capital 0 USD -100%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 41.4M USD +6.43%
Deferred Tax Assets, Net of Valuation Allowance 93.8M USD -4.48%
Share-based Payment Arrangement, Expense 18.1M USD +9.04%
Interest Expense 700K USD -75.9%